Bailly Christian
OncoWitan, Scientific Consulting Office, Wasquehal, F-59290 Lille, France.
Institut de Chimie Pharmaceutique Albert Lespagnol (ICPAL), Faculté de Pharmacie, University of Lille, 3 rue du Professeur Laguesse, BP-83, F-59006 Lille, France.
Plants (Basel). 2023 Feb 13;12(4):827. doi: 10.3390/plants12040827.
The genus in the family includes about 40 species, such as the well-known plants L. (common rue) or L. (fringed rue), but also much lesser-known species such as Pers. (narrow-leaved fringed rue). This rue specie, originating from the Mediterranean region, is well-distributed in Southeast Asia, notably in the Indo-Chinese peninsula and other territories. In some countries, such as Malaysia, the plant is used to treat liver diseases and cancer. Extracts of display antifungal, antiviral and antiparasitic effects. Diverse bioactive natural products have been isolated from the aerial parts of the plant, notably quinoline alkaloids and furocoumarins, which present noticeable anti-inflammatory, antioxidant and/or antiproliferative properties. The present review discusses the main pharmacological properties of the plant and its phytoconstituents, with a focus on the anticancer activities evidenced with diverse alkaloids and terpenoids isolated from the aerial parts of the plant. Quinoline alkaloids such as graveoline, kokusaginine, and arborinine have been characterized and their mode of action defined. Arborinine stands as a remarkable inhibitor of histone demethylase LSD1, endowed with promising anticancer activities. Other anticancer compounds, such as the furocoumarins chalepin and rutamarin, have revealed antitumor effects. Their mechanism of action is discussed together with that of other bioactive natural products, including angustifolin and moskachans. Altogether, Pers. presents a rich phytochemical profile, fully consistent with the traditional use of the plant to treat cancer. This rue species, somewhat neglected, warrant further investigations as a medicinal plant and a source of inspiration for drug discovery and design.
该科中的属包括约40个物种,如著名的植物芸香L.(普通芸香)或边缘芸香L.,但也有许多不太知名的物种,如窄叶边缘芸香Pers.。这种芸香物种原产于地中海地区,在东南亚分布广泛,特别是在印度支那半岛和其他地区。在一些国家,如马来西亚,这种植物被用于治疗肝脏疾病和癌症。窄叶边缘芸香的提取物具有抗真菌、抗病毒和抗寄生虫作用。从该植物地上部分分离出了多种具有生物活性的天然产物,特别是喹啉生物碱和呋喃香豆素,它们具有显著的抗炎、抗氧化和/或抗增殖特性。本综述讨论了该植物及其植物成分的主要药理特性,重点关注从植物地上部分分离出的多种生物碱和萜类化合物所证实的抗癌活性。喹啉生物碱如重氮oline、钩吻素甲和山豆根碱已被鉴定并确定了其作用模式。山豆根碱是一种显著的组蛋白去甲基化酶LSD1抑制剂,具有有前景的抗癌活性。其他抗癌化合物,如呋喃香豆素查莱平(chalepin)和鲁他马林(rutamarin),也显示出抗肿瘤作用。它们的作用机制与其他生物活性天然产物,包括狭叶香豆素(angustifolin)和莫斯卡香豆素(moskachans)的作用机制一起进行了讨论。总之,窄叶边缘芸香Pers.呈现出丰富的植物化学特征,与该植物治疗癌症的传统用途完全一致。这种有点被忽视的芸香物种,作为一种药用植物以及药物发现和设计的灵感来源,值得进一步研究。